Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Sofosbuvir Plus Daclatasvir in Patients With Chronic Hepatitis c Virus and Assessment of Resistance Associated Variants in Resistant and Relapsed Cases

NCT03572140 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03572140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03572140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Sofosbuvir Plus Daclatasvir in Patients With Chronic Hepatitis c Virus and Assessment of Resistance Associated Variants in Resistant and Relapsed Cases
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2018
Completion date
August 1, 2020
Enrollment
297 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcv